Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HABES herbal syrup and Golnar capsule versus tranexamic acid for abnormal uterine bleeding
IRCT20251221068398N1Phase 2Recruiting
- Sponsor
- Booali Pharmaceutical Company
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of punica granatum pleniflora and tranexamic acid in menstrual disorders and hypermenorrhea (3 arms), sponsored by Booali Pharmaceutical Company. Primary endpoints: Reduction in menstrual bleeding severity, Reduction in duration of menstrual bleeding and 1 more. Started Feb 2026; status: recruiting.
02
Drugs
punica granatum plenifloratranexamic acid
03
Conditions
menstrual disordershypermenorrhea
Beyond the preview
Go deeper on IRCT20251221068398N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251221068398N1.